TRACI ATKINS: Open Payments
NPI 1235274663 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 26 payments from 11 companies in 2025. Trend: 2023 $612 · 2024 $854 · 2025 $649
Food & beverage: $579Education: $70
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $138 |
| ABBVIE INC. | 5 | $101 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Galderma Laboratories, L.P. | 1 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $25 |
| GENZYME CORPORATION | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, COSENTYX, SKYRIZI, NEMLUVIO, TALTZ, SPEVIGO, CIBINQO.
Industry payments across KY — which companies pay providers there.
